Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

GÜLNİHAL ÖZCAN

Doçent

Ankara Üniversitesi Tıp Fakültesi Dahili Tıp Bilimleri Bölümü

Research topics OpenAlex
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Tıbbi Farmakoloji
Articles 26 YÖKSİS 17 · OpenAlex 9 Total citations 857 h-index 10 · OpenAlex Q1 articles 10 Scopus · WoS Q1 4 Best field rank #13,882 / 39,749 Main field · top 34.9% Co-authors 37 3 Turkish institutions

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 26 + YÖKSİS · co-author record: 1
h-index 10 Percentile in Türkiye: 81 #698 of 2,562 at their university by h-index
i10-index
10
Total citations
857
Top 6.1% in Türkiye
Per article
31.7
FWCI
2.86
1.00 = world average
World top 1%
1
World top 10%
6

Most cited articles

  1. Preclinical and clinical development of siRNA-based therapeutics 2015 world top 1% 452 citations
  2. Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer. 2022 world top 10% 86 citations
  3. Adverse Drug Reaction Reporting Pattern in Turkey: Analysis of the National Database in the Context of the First Pharmacovigilance Legislation 2016 world top 10% 70 citations
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 1 articles (17 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list. h-index on the OpenAlex author profile: 9.

Field ranking

YÖKSİS ?

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
37
With an akaturk profile
9
Turkish institutions
3
Co-authored works
%54

Academic co-authors 9

  1. HASAN ONGUN ONARAN Profesör · Ankara Üniversitesi same university 2
  2. SAFİYE ÇAVDAR Profesör · Koç Üniversitesi 2
  3. ÖZLEM UĞUR Profesör · Ankara Üniversitesi same university 2
  4. İLKE ALİ GÜRSES Profesör · Koç Üniversitesi 2
  5. ECE ÖZMEN Araştırma Görevlisi · İzmir Yüksek Teknoloji Enstitüsü 1
  6. EMRULLAH GÖRKEM GÜNBAŞ Profesör · Orta Doğu Teknik Üniversitesi 1
  7. SAFACAN KÖLEMEN Doçent · Koç Üniversitesi 1
  8. SEDAT HAKAN ORER Profesör · Koç Üniversitesi 1
  9. SİNEM EZGİ GÜLMEZ Profesör · Koç Üniversitesi 1

National collaboration 3 institutions

Within own university2 joint works · Ankara Üniversitesi

  1. Koç Üniversitesi 4 works · 5 academics
  2. Orta Doğu Teknik Üniversitesi 1 works · 1 academics
  3. İzmir Yüksek Teknoloji Enstitüsü 1 works · 1 academics

Other co-authors (incl. international) 28

TEVRİZ DİLAN DEMİR 3Ali İ Kaya 2CEMRE UÇARYILMAZ METİN 2DAMLASU ALTUNÖZ 2YILMAZ Emine DEMİREL 2ÖZEN LEYLEK 2Acar BayraktaroğluAnil K SoodBasar CenikBulent OzpolatCaterina AmbrosioEbru ŞenEmel AykacEmire Ayşe ŞAHİNGabriel Lopez-BeresteinGİZEM ATAKAN ALKANMegan E. HoneywellMehmet Kursat DericiMichael J. LeeMichael T. HemannN Demet AydinkarahalilogluNergiz T NemutluRobert L ColemanSezen BallıT CostaTOUGHRUL ALMAMMADOVYelda KasapŞ Sadık Öner

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.

Indexes and citation percentiles

?
TR Index 1 articles
OpenAlex citation percentile
Top 1%1
Top 10%6
Avg · n 21 %68.4
Other counts

Scopus (SJR)

  • YÖKSİS rows 17

WoS (JCR)

  • YÖKSİS rows 16

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

26articles

Journals with publications

17 journals

Narrow down

Scopus (SJR)
Q110 Q26 Q30 Q41
WoS (JCR)
Q14 Q29 Q31 Q42
TR Index
1articles

Article list

  1. 2025 The integration of the British Pharmacological Societys prescription safety assessment into the WHO 6‐step model of rational pharmacotherapy in a Turkish medical school British Journal of Clinical Pharmacology DOI 10.1002/bcp.70146 YÖKSİS SJR Q1 JCR Q2 OpenAlex 74.3%
  2. 2024 Cancer-associated fibroblasts: protagonists of the tumor microenvironment in gastric cancer Frontiers in Molecular Biosciences DOI 10.3389/fmolb.2024.1340124 YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 98.5%
  3. 2024 Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy Gastric Cancer DOI 10.1007/s10120-024-01537-y YÖKSİS SJR Q1 JCR Q1 OpenAlex 65.2%
  4. 2024 Extracranial transport of brain lymphatics via cranial nerve in human Neuroscience Letters DOI 10.1016/j.neulet.2024.137737 YÖKSİS SJR Q2 JCR Q4 OpenAlex 84.4%
  5. 2024 Brain lymphatic vessels accompanying meningeal arteries in the human Translational Research in Anatomy DOI 10.1016/j.tria.2024.100321 YÖKSİS SJR Q2 JCR Q2 OpenAlex 60.9%
  6. 2023 PTCH1 and CTNNB1 emerge as pivotal predictors of resistance to neoadjuvant chemotherapy in ER+/HER2- breast cancer Frontiers in Oncology DOI 10.3389/fonc.2023.1216438 YÖKSİS SJR Q2 JCR Q2 OpenAlex 72.7%
  7. 2023 The hypoxia-inducible factor-1α in stemness and resistance to chemotherapy in gastric cancer: Future directions for therapeutic targeting. Frontiers in cell and developmental biology DOI 10.3389/fcell.2023.1082057 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 92.6%
  8. 2023 SCUBE2 as a Marker of Resistance to Taxane-based Neoadjuvant Chemotherapy and a Potential Therapeutic Target in Breast Cancer Eur J Breast Health. DOI 10.4274/ejbh.galenos.2022.2022-8-2 YÖKSİS TR Index SJR Q2 JCR Q4 OpenAlex 64.1%
  9. 2022 The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer. Cancers DOI 10.3390/cancers14112711 YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 94.4%
  10. 2022 Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer. BMC cancer DOI 10.1186/s12885-022-09736-5 YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 98.3%
  11. 2020 Resorufin Enters the Photodynamic Therapy Arena: A Monoamine Oxidase Activatable Agent for Selective Cytotoxicity ACS MEDICINAL CHEMISTRY LETTERS DOI 10.1021/acsmedchemlett.0c00484 YÖKSİS SJR Q1 JCR Q2 OpenAlex 73.7%
  12. 2016 Effect of Nitric Oxide on Cardiac Functions: Review Turkiye Klinikleri Cardiovascular Sciences DOI 10.5336/cardiosci.2016-53254 YÖKSİS SJR Q4 OpenAlex 67.1%
  13. 2016 Adverse Drug Reaction Reporting Pattern in Turkey: Analysis of the National Database in the Context of the First Pharmacovigilance Legislation Drugs - Real World Outcomes DOI 10.1007/s40801-015-0054-1 YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 94.4%
  14. 2015 Preclinical and clinical development of siRNA-based therapeutics Advanced Drug Delivery Reviews DOI 10.1016/j.addr.2015.01.007 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.8%
  15. 2012 Various Phosphodiesterase Activities in Different Regions of the Heart Alter the Cardiac Effects of Nitric Oxide Journal of Cardiovascular Pharmacology DOI 10.1097/FJC.0b013e31825f3eeb YÖKSİS SJR Q1 JCR Q2 OpenAlex 54.1%
  16. 2012 Cell Contact-dependent Functional Selectivity of 2-Adrenergic Receptor Ligands in Stimulating cAMP Accumulation and Extracellular Signal-regulated Kinase Phosphorylation Journal of Biological Chemistry DOI 10.1074/jbc.M111.301820 YÖKSİS SJR Q1 JCR Q1 OpenAlex 81.9%
  17. 2010 β2-Adrenoceptor, Gs and adenylate cyclase coupling in purified detergent-resistant, low density membrane fractions European Journal of Pharmacology DOI 10.1016/j.ejphar.2009.12.035 YÖKSİS SJR Q2 JCR Q2 OpenAlex 57.1%

← Back to academicians